You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 10/20/2014

Company Name Symbol %Change
ONCOLYTICS B ONCY
19.07%
TUBEMOGUL IN TUBE
13.15%
DEJOUR ENERG DEJ
11.80%
POST HOLDING POST
8.90%
SUNEDISON IN SUNE
7.70%
Omnicell unveils G4 Unity platform

Print Share

Dec 17, 2012 (Datamonitor via COMTEX) -- Omnicell, Inc., a provider of medication and supply management solutions and analytics software for healthcare facilities, has announced the availability of G4 Unity platform.

According to the company, the G4 Unity platform features a single, shared medication database that connects all G4 Unity solutions to enable complete medication and supply tracking from the controlled substance vault to medication and supply cabinets, the OR and to the bedside. The unified database also helps to eliminate redundant data entry that can lead to errors.

The platform is powered by the enterprise-class OmniCenter server, which centrally manages Omnicell medication and supply dispensing systems and stores up to seven years of data, enabling quick retrieval and analysis of extended historical information.

The ability to store seven years of data is a critical and growing compliance factor in several US states. G4 Unity solutions leverage robust software, computing power and hardware from Microsoft, Intel and Dell, the company said.

The G4 Unity platform offers capabilities that enhance the user experience, and provides a foundation for ongoing innovations to keep pace with changing regulatory and workflow requirements.

In addition, the G4 Unity solutions allow hospitals to connect to electronic health records and other healthcare information systems to improve functionality and simplify system administration, the company added.

With the new software release, Omnicell has also enhanced the existing medication and supply dispensing technology for the long-term non-acute care market by adding the ability to support multiple time zones from a single server. This allows users such as institutional pharmacies to streamline operations, reduce costs and simplify reporting.

"Omnicell has a long history of delivering meaningful innovations. In the past 20 years, we have provided our customers with 17 major system upgrades," said Marga Ortigas-Wedekind, Omnicell vice president, global marketing and product development.

"Our new G4 Unity platform delivers a host of benefits that optimize clinicians' time and help ensure a consistent experience across all Omnicell Unity Products. For example, the G4 Unity platform's single medication database streamlines data entry, minimizes system maintenance and IT involvement, and centralizes updates to patient information. Omnicell is committed to providing ongoing product enhancements that allow our customers to improve the standard of care."

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon

Copyright (C) 2012 Datamonitor. All rights reserved

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.